Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.77 CAD | -0.56% | 0.00% | -17.29% |
Sales 2024 * | 120M 87.77M | Sales 2025 * | 132M 96.65M | Capitalization | 81.85M 60.04M |
---|---|---|---|---|---|
Net income 2024 * | -4M -2.93M | Net income 2025 * | -6M -4.4M | EV / Sales 2024 * | 0.68 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.62 x |
P/E ratio 2024 * |
-15.5
x | P/E ratio 2025 * |
-14.8
x | Employees | 103 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.58% |
Latest transcript on Theratechnologies Inc.
1 day | -0.56% | ||
1 month | -1.12% | ||
3 months | -15.31% | ||
6 months | -12.38% | ||
Current year | -17.29% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Lévesque
CEO | Chief Executive Officer | 60 | 20-04-05 |
Philippe Dubuc
DFI | Director of Finance/CFO | 57 | 16-02-23 |
Chief Tech/Sci/R&D Officer | 61 | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Molson
BRD | Director/Board Member | 56 | 20-10-15 |
Frank Holler
CHM | Chairman | 67 | 21-06-22 |
Director/Board Member | 68 | 17-05-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-27 | 1.77 | -0.56% | 2,730 |
24-05-24 | 1.78 | +4.09% | 13,684 |
24-05-23 | 1.71 | -2.84% | 12,200 |
24-05-22 | 1.76 | -0.56% | 7,511 |
Delayed Quote Toronto S.E., May 27, 2024 at 03:55 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.29% | 59.91M | |
-2.10% | 90.02B | |
-0.66% | 39.15B | |
-15.83% | 31.71B | |
+62.42% | 26.47B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-10.32% | 11.18B | |
-45.77% | 10.97B | |
+3.45% | 8.94B |
- Stock Market
- Equities
- TH Stock